4//SEC Filing
Huff James Warren 4
Accession 0001209191-23-041925
CIK 0001358762other
Filed
Jul 9, 8:00 PM ET
Accepted
Jul 10, 4:38 PM ET
Size
25.1 KB
Accession
0001209191-23-041925
Insider Transaction Report
Form 4
Huff James Warren
DirectorSee Remarks
Transactions
- Award
Employee Stock Option (right-to-buy)
2023-07-06+275,436→ 275,436 totalExercise: $25.03Exp: 2032-09-29→ Class A common stock (275,436 underlying) - Award
Class A common stock
2023-07-06+11,656→ 49,916 total - Award
Class A common stock
2023-07-06+72,564→ 122,480 total
Holdings
- 212,903
Class B common stock
→ Class A common stock (212,903 underlying) - 28,625
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (28,625 underlying) - 146,824
Employee Stock Option (right-to-buy)
Exercise: $36.71Exp: 2033-01-03→ Class A common stock (146,824 underlying) - 124,600
Employee Stock Option (right to buy)
Exercise: $24.75Exp: 2027-12-06→ Class B common stock (124,600 underlying) - 10,398(indirect: By The 2021 JWH GRAT)
Class A common stock
- 51,818
Employee Stock Option (right to buy)
Exercise: $11.00Exp: 2026-05-25→ Class B common stock (51,818 underlying) - 28,625
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (28,625 underlying) - 99,950
Employee Stock Option (right to buy)
Exercise: $22.57Exp: 2026-12-07→ Class B common stock (99,950 underlying) - 57,250
Employee Stock Option (right to buy)
Exercise: $55.73Exp: 2029-01-02→ Class B common stock (57,250 underlying) - 20,133
Employee Stock Option (right to buy)
Exercise: $207.20Exp: 2030-01-02→ Class B common stock (20,133 underlying) - 23,968
Employee Stock Option (right to buy)
Exercise: $121.29Exp: 2031-01-04→ Class A common stock (23,968 underlying)
Footnotes (14)
- [F1]The shares represent Restricted Stock Units granted with performance criteria (PSUs). On December 17, 2020, the reporting person was granted 11,656 PSUs. On July 6, 2023, based on certain performance criteria, the PSUs vested as to 2,914 shares, with the remainder vesting 1/12th on each subsequent 3 month anniversary, subject to continued service through each vesting date.
- [F10]On October 14, 2019, based on the satisfaction of certain performance criteria, the option vested as to 7,156 shares and the option was set to vest as to 21,469 shares in twelve equal quarterly installments beginning on January 14, 2020, subject to continued service through each vesting date.
- [F11]On November 11, 2019, based on the satisfaction of certain performance criteria, the option vested as to 7,156 shares and the option was set to vest as to 21,469 shares in twelve equal quarterly installments beginning on February 11, 2020, subject to continued service through each vesting date.
- [F12]The options vest in sixteen equal quarterly installments beginning on April 2, 2020, subject to continued service through each vesting date.
- [F13]The options vest in sixteen equal quarterly installments beginning on April 4, 2021, subject to continued service through each vesting date.
- [F14]The options vest 1/16th of each grant on March 6, May 15, August 15, and November 15 of each year, subject to continued service through each vesting date.
- [F2]Reflects the transfer of 2,102 shares of Class A common stock previously reported as indirectly held by The 2021 JWH GRAT to the Reporting Person directly.
- [F3]The shares represent Restricted Stock Units granted with performance criteria (PSUs). On September 29, 2022, the reporting person was granted 72,564 PSUs. On July 6, 2023, based on certain performance criteria, the PSUs are set to vest 1/12th each quarter beginning on October 6, 2023, subject to continued service through each vesting date.
- [F4]On September 29, 2022, the reporting person was granted an option to purchase 275,436 shares of Class A common stock subject to performance criteria. On July 6, 2023, based on certain performance criteria, the options are set to vest 1/12th each quarter beginning on October 6, 2023, subject to continued service through each vesting date.
- [F5]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F6]The options vested in sixteen equal quarterly installments beginning on August 25, 2016.
- [F7]The options vested in twenty equal quarterly installments beginning on March 7, 2017.
- [F8]The options vested in sixteen equal quarterly installments beginning on March 6, 2018.
- [F9]The options vested in sixteen equal quarterly installments beginning on April 2, 2019.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662411
Filing Metadata
- Form type
- 4
- Filed
- Jul 9, 8:00 PM ET
- Accepted
- Jul 10, 4:38 PM ET
- Size
- 25.1 KB